Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
495
NCT00274300
Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2004
Completion: Jul 31, 2005
NCT00277576
Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection
Start: Jan 31, 2006
Completion: Dec 31, 2007
NCT00310271
A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects
Start: Apr 30, 2006
Completion: Dec 31, 2006
NCT00347529
Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu
Start: Aug 31, 2006
Completion: Jan 31, 2007
NCT00349037
Study of the Ability of a Flu Vaccine to Prevent Flu Infection
Start: Sep 30, 2006
NCT00375206
A Safety and Immunology Study of a DNA Trivalent Influenza Vaccine